Mason Carrico

Stock Analyst at Stephens & Co.

(0)
# 4360
Out of 5,175 analysts
78
Total ratings
20.97%
Success rate
-17.32%
Average return
19 Stocks
Name Action Price Target Current % Upside Ratings Updated
VCYT Veracyte
Reiterates: Overweight
45 45
31.41 43.27% 6 Mar 26, 2025
OCX OncoCyte
Reiterates: Equal-Weight
4 4
2.95 35.59% 5 Mar 26, 2025
GH Guardant Health
Reiterates: Overweight
55 55
45.67 20.43% 5 Mar 26, 2025
AKYA Akoya Biosciences
Downgrades: Equal-Weight
4 2
1.28 40.62% 6 Mar 25, 2025
CTKB Cytek Biosciences
Reiterates: Overweight
6 6
3.77 59.15% 2 Mar 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
17 17
17.41 -2.35% 2 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
156 156
76.23 104.64% 7 Mar 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
52 52
29.85 74.2% 2 Mar 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
40 40
17.84 124.22% 9 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
3 3
1.16 115.52% 4 Feb 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
84 84
58.18 44.38% 3 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
14 13
13.09 -0.69% 1 Jan 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
20 20
7.29 174.35% 4 Jan 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
40.07 62.22% 1 Jan 15, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
41 41
21.27 92.76% 7 Jan 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
30 30
8.02 274.06% 5 Oct 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
125 125
148.62 -15.89% 4 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
19 19
9.91 91.73% 1 Jul 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
2 2
0.09 1566.67% 4 Apr 19, 2024